Filing Details

Accession Number:
0001093557-25-000218
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-06-18 16:31:58
Reporting Period:
2025-06-16
Filing Date:
2025-06-18
Accepted Time:
2025-06-18 16:31:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1093557 Dexcom Inc DXCM Surgical & Medical Instruments & Apparatus (3841) 330857544
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236389 G Mark Foletta 6340 Sequence Drive
San Diego CA 92121
Yes No No No
Transaction Summary
Sold: 2,750 shares Avg. Price: $83.13 Total Value: $228,604.75
Number of Shares After Transactions: 56,621 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-06-16 2,750 $83.13 56,621 No 4 S Indirect by Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect by Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,731 Direct
Footnotes
  1. On March 13, 2025, The Foletta Family Trust DTD 1/30/2015 (the "Trust") adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by the Trust. The shares set forth above were sold pursuant to the 10b5-1 Plan.
  2. This transaction was executed in multiple trades at prices ranging from $82.635 to $83.61. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  3. Shares are held by The Foletta Family Trust DTD 1/30/2015, with respect to which the reporting person is a trustee.
  4. Represents unvested restricted stock units which were granted on May 8, 2025 and shall vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders.